Gujarat Terce Labs Reports Strong Financial Performance in Q2 2024
Gujarat Terce Laboratories, a microcap pharmaceutical company, has reported a positive financial performance in the second quarter of fiscal year 2024-2025. Key indicators such as Profit Before Tax, Net Sales, Operating Profit, and Profit After Tax have shown significant improvement, indicating a promising future for the company in the pharmaceutical industry.
Gujarat Terce Laboratories, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.According to the financial report, Gujarat Terce Labs has shown a very positive performance in the second quarter of the fiscal year 2024-2025. The company's score has improved from 5 to 20 in the last three months.
One of the key factors contributing to this positive performance is the growth in Profit Before Tax less Other Income (PBT) which has increased by 291.8% to Rs 1.43 crore compared to the average PBT of the previous four quarters which was Rs 0.37 crore. This indicates a very positive trend in the near term for PBT.
The company has also seen a significant increase in its Net Sales, which reached a high of Rs 13.30 crore in the last five quarters. This shows a positive trend in the near term for sales. Additionally, the Operating Profit (PBDIT) has also reached its highest at Rs 1.66 crore in the last five quarters, indicating a positive trend in the near term.
Moreover, the company's efficiency has improved as seen in the Operating Profit Margin, which reached its highest at 12.48% in the last five quarters. This is a positive sign for the company's financial health.
The Profit After Tax (PAT) has also shown a positive trend, reaching its highest at Rs 1.48 crore in the last five quarters. This is a good indication of the company's profitability.
Furthermore, the Earnings per Share (EPS) has also increased to its highest at Rs 1.99 in the last five quarters, showing that the company has created higher earnings for its shareholders.
Overall, Gujarat Terce Laboratories has shown a strong financial performance in the quarter ending September 2024, with positive trends in key financial indicators. This is a promising sign for the company's future growth and success in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
